Locum Respiratory Pharmacist - Portsmouth
Pulse HealthcarePortsmouth, England, United Kingdom · Posted 2 months agoDescription
Job Title: Locum Specialist Pharmacist – Respiratory
Banding: Band 7
Location: Portsmouth
Start Date: ASAP
Duration: Ongoing
Hourly Rate: £30-31
Working Hours: 37.5 hours per week (Thursday & Friday essential), 08:30–17:00
Job Overview
Pulse is currently seeking experienced Band 7 Specialist Pharmacists to join the Respiratory Pharmacy team (multiple positions). This role offers an excellent opportunity to lead and develop clinical pharmacy services within the respiratory directorate, ensuring high-quality, patient-centred care. The successful candidates will play a key role in optimising medicines use, supporting clinical teams, and driving service improvements within respiratory medicine.
Key Responsibilities
- Lead the delivery and development of clinical pharmacy services for respiratory patients.
- Provide expert pharmaceutical advice to ensure safe, effective, and cost-efficient use of medicines.
- Support medicines optimisation and contribute to improved patient outcomes.
- Undertake risk management and ensure compliance with medicines legislation.
- Drive financial efficiencies and savings within respiratory services.
- Deliver education and training programmes relevant to respiratory pharmacy.
Qualifications and Experience
- Registered Pharmacist with the General Pharmaceutical Council (GPhC).
- Experience working at Band 7 level or equivalent in a hospital setting.
- Clinical experience in respiratory medicine (desirable).
- Strong knowledge of medicines optimisation and governance.
- Excellent communication, leadership, and organisational skills.
Why Choose Pulse?
From the moment you register with Pulse, our focus is entirely on you. Our specialist recruitment consultants understand your profession and are committed to finding the right opportunities to match your skills and aspirations. With exclusive access to roles across the UK, we offer a personalised and supportive recruitment experience that puts your career first.
How to Apply
If you’re interested in registering with Pulse, learning more about this role, or exploring additional opportunities, we’d love to hear from you. Please apply using the link below.
Reasonable Adjustments
If you have a disability or require any reasonable adjustments during the recruitment process or within the workplace, please let us know as early as possible. We are committed to providing the support you need throughout your journey with Pulse.
International Recruitment Notice
Please note that we are unable to accept applications from individuals residing in countries listed on the Red or Amber list of the Code of Practice for the International Recruitment of Health and Social Care Personnel in England, as defined by the World Health Organisation (WHO) Workforce Support and Safeguard List.
Similar jobs
Est. 80,000 GBP
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 55,000 GBP
We invite you to come grow with us. Inizio Ignite is the global advisory partner for health and life sciences, encompassing connected expertise across Research Partnership, Putnam, Vynamic, and STEM. Guided by purpose, p…
Est. 120,000 GBP
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 247,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 65,000 GBP
About us: We invite you to come grow with us. Inizio Ignite is the global advisory partner for health and life sciences, encompassing connected expertise across Research Partnership, Putnam, Vynamic, and STEM. Guided by…
Est. 197,600 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 197,600 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 197,600 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 120,000 GBP
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 247,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 60,000 GBP
Who we are: Burson, part of WPP, is the global communications leader built to create value for clients through reputation. With highly specialized teams, industry-leading technologies and breakthrough creative, we help b…
Est. 80,000 GBP
We invite you to come grow with us. Inizio Ignite is the global advisory partner for health and life sciences, encompassing connected expertise across Research Partnership, Putnam, Vynamic, and STEM. Guided by purpose, p…
Est. 85,000 GBP
We invite you to come grow with us. Inizio Ignite is the global advisory partner for health and life sciences, encompassing connected expertise across Research Partnership, Putnam, Vynamic, and STEM. Guided by purpose, p…
Est. 247,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 242,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 55,000 GBP
Who we are: Burson, part of WPP, is the global communications leader built to create value for clients through reputation. With highly specialized teams, industry-leading technologies and breakthrough creative, we help b…
Est. 274,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 247,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 247,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 180,000 USD
Company introduction: Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. The Company is headquartered in London, UK, with a…
Est. 180,000 USD
Company introduction: Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. The Company is headquartered in London, UK, with a…
Est. 65,000 GBP
About Ogilvy Ogilvy, part of WPP, was founded in 1948 by David Ogilvy. David created a culture that deeply respects and cares about its people and clients. Our mission is to inspire people and brands to make an impact an…
Est. 180,000 USD
Company introduction: Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. The Company is headquartered in London, UK, with a…
Est. 274,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 283,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 55,000 GBP
General Opportunity - Account Management – Incisive Health (health policy) In the journey of life, your career should make a difference. At Incisive Health, we come together—to do the best work, in the best possible plac…
Est. 226,000 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 180,000 USD
Company introduction: Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. The Company is headquartered in London, UK, with a…
Est. 120,000 GBP
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 180,000 USD
Company introduction: Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. The Company is headquartered in London, UK, with a…